Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity

Hiromu Tanaka, Erika Toya, Shotaro Chubachi, Ho Namkoong, Takanori Asakura, Shuhei Azekawa, Shiro Otake, Kensuke Nakagawara, Takahiro Fukushima, Mayuko Watase, Kaori Sakurai, Katsunori Masaki, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga

Open source

DOI
10.1016/j.resinv.2024.09.011
Published
2024-11
Container
Respiratory Investigation
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.resinv.2024.09.011,
  title = {Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity},
  author = {Hiromu Tanaka and Erika Toya and Shotaro Chubachi and Ho Namkoong and Takanori Asakura and Shuhei Azekawa and Shiro Otake and Kensuke Nakagawara and Takahiro Fukushima and Mayuko Watase and Kaori Sakurai and Katsunori Masaki and Hirofumi Kamata and Makoto Ishii and Naoki Hasegawa and Yukinori Okada and Ryuji Koike and Yuko Kitagawa and Akinori Kimura and Seiya Imoto and Satoru Miyano and Seishi Ogawa and Takanori Kanai and Koichi Fukunaga},
  year = {2024},
  journal = {Respiratory Investigation},
  doi = {10.1016/j.resinv.2024.09.011},
  url = {https://doi.org/10.1016/j.resinv.2024.09.011}
}

RIS

TY  - JOUR
TI  - Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity
AU  - Hiromu Tanaka
AU  - Erika Toya
AU  - Shotaro Chubachi
AU  - Ho Namkoong
AU  - Takanori Asakura
AU  - Shuhei Azekawa
AU  - Shiro Otake
AU  - Kensuke Nakagawara
AU  - Takahiro Fukushima
AU  - Mayuko Watase
AU  - Kaori Sakurai
AU  - Katsunori Masaki
AU  - Hirofumi Kamata
AU  - Makoto Ishii
AU  - Naoki Hasegawa
AU  - Yukinori Okada
AU  - Ryuji Koike
AU  - Yuko Kitagawa
AU  - Akinori Kimura
AU  - Seiya Imoto
AU  - Satoru Miyano
AU  - Seishi Ogawa
AU  - Takanori Kanai
AU  - Koichi Fukunaga
PY  - 2024
JO  - Respiratory Investigation
DO  - 10.1016/j.resinv.2024.09.011
UR  - https://doi.org/10.1016/j.resinv.2024.09.011
ER  - 

APA

Tanaka, H., Toya, E., Chubachi, S., Namkoong, H., Asakura, T., Azekawa, S., Otake, S., Nakagawara, K., Fukushima, T., Watase, M., Sakurai, K., Masaki, K., Kamata, H., Ishii, M., Hasegawa, N., Okada, Y., Koike, R., Kitagawa, Y., Kimura, A., Imoto, S., Miyano, S., Ogawa, S., Kanai, T., & Fukunaga, K. (2024). Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity. Respiratory Investigation. https://doi.org/10.1016/j.resinv.2024.09.011

Source records